Show simple item record

DEVELOPMENT OF GD2 TARGETING THERANOSTICS FOR NEUROBLASTOMA

dc.rights.licenseCC-BY-NC-ND
dc.contributor.advisorPoot, A.J.
dc.contributor.authorSünnen, Emma
dc.date.accessioned2023-12-09T00:01:04Z
dc.date.available2023-12-09T00:01:04Z
dc.date.issued2023
dc.identifier.urihttps://studenttheses.uu.nl/handle/20.500.12932/45627
dc.description.sponsorshipUtrecht University
dc.language.isoEN
dc.subjectUsing the concept of theranosics to modify the antibody Dinutuximab, an approved medicine for treatment of neuroblastoma, with as goal to have a better understanding of the antibody.
dc.titleDEVELOPMENT OF GD2 TARGETING THERANOSTICS FOR NEUROBLASTOMA
dc.type.contentMaster Thesis
dc.rights.accessrightsOpen Access
dc.subject.courseuuDrug Innovation
dc.thesis.id26455


Files in this item

Thumbnail
Name:
Final_Report_Major_Research_Pr ...
Size:
517.3Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record